[1]
“HYPOTENSIVE AND HYPERTENSIVE AGENTS: MECHANISMS, DOSE–RESPONSE RELATIONSHIPS, CLINICAL USE, ADVERSE EFFECTS, AND SAFETY PRINCIPLES”, ITFTTDM, vol. 4, no. 2, pp. 299–308, Feb. 2026, Accessed: May 18, 2026. [Online]. Available: https://universalpublishings.com/index.php/itfttdm/article/view/16816